A single world-class asset (24.99% of Greenbushes) wearing the corpse of a failed nickel-and-refinery empire — re-rated 124% on the lithium-price bounce, now priced for the recovery to keep going while the asset itself springs structural leaks (grade decline + CGP3 fire). Quality mine, broken portfolio, expensive entry. WATCHING.
No Friday close is on the record for IGO.AX yet. The weekly job prices the covered universe; a name it cannot price is listed as missing rather than estimated.
The verdict
A single world-class orebody (24.99% of Greenbushes, with no control) wearing the corpse of a value-destroying nickel-and-refinery empire — re-rated ~124% on the lithium bounce to near a 52-wk high, now priced for the recovery to keep running while the asset itself springs structural leaks (mined grade declining toward the 1.6% resource average + a CGP3 fire at the growth plant + a finance function that just lost a CFO after 29 days). Quality mine, broken portfolio, expensive entry. WATCHING, lean BEARISH on a 6–12M view.
IGO Ltd is a Perth-based ASX-listed miner that, after a brutal two-year self-reinvention, is now essentially a single-asset, no-control lithium royalty wrapped in a winding-down nickel business. Stripped to its economics, IGO is three things stacked on top of each other:
The crown jewel — 24.99% indirect economic interest in Greenbushes. Through the Tianqi Lithium Energy Australia (TLEA) joint venture, IGO holds an indirect 24.99% economic interest in the Greenbushes Lithium Operation in Western Australia. Greenbushes is the largest and lowest-cost hard-rock lithium mine on Earth, supplying >20% of global high-grade lithium concentrate. The ownership chain: TLEA (Tianqi 51% / IGO 49%) owns 51% of Talison Lithium, which owns Greenbushes; Albemarle owns the other 49% of Talison. Net to IGO: 49% × 51% = 24.99% of the mine's economics. This stake is the overwhelming majority of IGO's intrinsic value.
The albatross — 49% indirect interest in the Kwinana Lithium Hydroxide Refinery. TLEA owns 100% of Kwinana; IGO's 49% of TLEA gives it a 49% indirect interest. Kwinana was meant to capture downstream lithium-chemical margin. Instead, after three years of operation it reached only ~35% of nameplate capacity, IGO recorded a A$605M full impairment in FY25 (plus A$58M de-recognition of related deferred tax assets), Vella has said publicly "it is just not working" and "we don't see that pathway there," and IGO is in talks with Tianqi over a full exit. Crucially, Tianqi has confirmed it intends to retain control and is not shutting Kwinana down, and TLEA suspended Train 2 construction in January — so IGO can leave only on Tianqi's terms, if at all.
The wind-down — 100%-owned nickel. The Nova nickel-copper-cobalt mine (Fraser Range, WA) is IGO's only wholly-owned producing operation and reaches end-of-life by late calendar-2026; rehabilitation works begin in 2027 as a multi-year program. Forrestania ceased production Sept-2024 and was sold to Medallion Metals for zero cash consideration (Medallion took the plant + rehabilitation liabilities) in early 2026. Cosmos — into which IGO sank A$500M+ — was mothballed (care & maintenance) in June-2024.
How it makes money. IGO's reported revenue is overwhelmingly Nova nickel concentrate sales (FY25 nickel revenue A$512M, down from A$823M FY24 ); the lithium economics flow through equity accounting — IGO's share of TLEA's net profit, plus distributions/dividends from Talison out of Free cash flowCash left after paying to run and maintain the business. Unlike profit, it is hard to flatter with accounting choices. — not consolidated revenue. This is the single most important structural fact about reading IGO: the asset that matters does not show up in the revenue line. It appears as "share of profit of associates" + cash distributions. So "IGO revenue" understates the business and "IGO EBITDA" is distorted — it bundles consolidated nickel losses while excluding the unconsolidated lithium profits IGO actually owns.
Customers / suppliers / competitors. End customers for Greenbushes spodumene are lithium converters — Tianqi and Albemarle take Greenbushes offtake at the Talison level, increasingly priced off a more frequently-reset (near-spot) formula. Nova nickel concentrate goes to a small set of offtake counterparties. Suppliers are standard mining inputs (diesel, reagents, mining contractors, grid power). Competitors as an investable lithium vehicle: Pilbara Minerals (PLS), Mineral Resources (MIN), Liontown (LTR) on the ASX, plus Albemarle and SQM globally (our figures empty — n/a in research layer).
Contract structure. No take-or-pay; spodumene priced off a frequently-reset formula tied to lithium-chemical prices. The most important "contract" is really the JV governance with Tianqi and Albemarle — IGO is a minority at every level (24.99% of the mine, 49% of TLEA) and therefore does not control its single most valuable asset. That is a structural governance fact, not a footnote.
Named, end-to-end. Spodumene → hydroxide/carbonate → cathode → cell → EV/ESS.
Upstream inputs → mine. Diesel, grinding media, flotation reagents, electricity (SW Interconnected System, WA), and mining contractors feed the Greenbushes open pit. Greenbushes is a hard-rock pegmatite; the CY25 Mineral Resource is 457Mt at 1.6% Li₂O (+4% mass / +9% contained Li₂O vs CY24) — but 2025 mined feed was 6.16Mt of ore at 1.9% Li₂O producing ~1.35Mt of concentrate. The gap between the ~1.9% being mined and the ~1.6% resource average is the quantified shape of the grade-decline story (see Lens 5).
The asset and its owners.
Midstream — conversion. Greenbushes spodumene (SC6, ~6% Li₂O concentrate) is shipped to converters. Offtake is split between the two JV strategics — Tianqi (China hydroxide/carbonate plants incl. Kwinana) and Albemarle (Kemerton, WA + global). Kwinana itself is the would-be domestic conversion node — and the broken link in the chain.
Downstream — cathode/cell/end-market. Hydroxide/carbonate → cathode active material (largely China) → cell makers (CATL, LG Energy Solution, Panasonic, BYD) → Enterprise valueWhat it would cost to buy the whole company: its market value plus its debt, minus the cash you would get with it. Often very different from market cap. OEMs + grid ESS. IGO has no presence below the refinery — its exposure ends at the spodumene/hydroxide gate.
Chokepoints / single-source dependencies.
The moat is the orebody, and it is real — but it is not IGO's moat, it is Greenbushes'. Greenbushes has a genuine, durable cost moat: it is the lowest-cost hard-rock lithium mine globally, posting a 66% EBITDA margin in FY25 (down from 85% in FY24) and ~75% in the March-2026 quarter even at suppressed spodumene prices. At the trough of the worst lithium bust in a decade, Greenbushes still generated ~A$1.5B of operating cash flow. That is a first-quartile — arguably first-decile — cost-curve position: the rare mining asset that earns above its cost of capital across the cycle. Moat sources: exceptional mined grade (~1.9% Li₂O vs ~1.0–1.3% for most peers), scale, integrated processing, and 40+ years of operating know-how.
But IGO's own moat is thin-to-nonexistent. Strip out Greenbushes and IGO is a sub-scale nickel miner in terminal decline plus a refinery it is trying to give away. The investable question is not "does IGO have a moat" — it's "is owning 24.99% of a great asset, with no control, at a public-market multiple, a good way to own that asset?" That is structurally weaker than owning the asset outright — which Albemarle and Tianqi effectively do.
Bargaining power.
Switching costs / network effects / IP: none meaningful at the IGO level. The durable advantage is purely the geological endowment of one mine, shared three ways — and that endowment is grading down.
our figures is empty in the research layer — all figures below are ``, on a 100%-asset basis (i.e. before applying IGO's 24.99%/49% economic share), which is how IGO reports JV-asset performance.
| Segment | FY25 revenue (100% basis) | FY25 EBITDA (100% basis) | Trend | Source |
|---|---|---|---|---|
| Greenbushes (24.99% IGO) | A$1,788M | A$1,173M (66% margin, FY24 85%) | Sharp deceleration — FY24 was A$4,638M rev / A$3,953M EBITDA. Revenue ~−61% YoY on a 64% fall in realised spodumene price; FY25 production 1,479kt @ A$325/t cash cost | |
| Kwinana refinery (49% IGO) | A$81M | −A$210M (EBITDA loss) | Loss narrowed from −A$356M FY24 but still deeply loss-making; ~35% of nameplate after 3 yrs; fully impaired (A$605M + A$58M DTA) | |
| Nova nickel (100% IGO) | A$512M (FY24 A$823M) | A$59M underlying (FY24 distorted) | 16,371t Ni + 7,324t Cu + 581t Co; ~A$5.53/lb Ni cash cost; realised Ni −10% YoY; end-of-life late-2026 | |
| Forrestania / Cosmos | — | impaired/closed | Forrestania sold for A$0 (early-2026); Cosmos C&M (Jun-2024) |
Geography: ~100% Western Australia. No meaningful geographic segmentation.
Group result FY25: statutory net loss after tax A$955M (vs A$3M profit FY24); underlying EBITDA −A$43M (vs +A$581M FY24). Provenance conflict flagged: one outlet (mining-technology.com / Yahoo) reports the FY25 net loss as A$619M rather than A$955M — the A$955M figure (IGO's own FY25 presentation, Mining Weekly, Australian Mining Review) appears to be the headline statutory loss attributable to members, while the A$619M may be a pre-some-items measure; not silently reconciled — both reported. The impairment stack behind the loss: A$605M Kwinana + A$58M Kwinana DTA + A$115M exploration write-off + A$58M increase in Nova/Cosmos/Forrestania rehab provisions. The swing from +A$581M to −A$43M underlying EBITDA in one year is the violence of a single-commodity downturn hitting a portfolio with no diversification left.
The read on the trend: Greenbushes decelerated hard but stayed massively profitable; everything else around it bled. The FY25 loss was manufactured by IGO's own non-Greenbushes assets (Kwinana + nickel/exploration impairments), not by the crown jewel. The 1H FY26 print confirms the inflection: net loss narrowed 96% to A$34.1M, underlying EBITDA +A$49M, IGO's share of TLEA net loss improved to just −A$1M (from −A$20M), Greenbushes 100%-basis EBITDA A$464M for the half. The business is turning the corner as lithium prices recover.
1H FY26 (reported 19-Feb-2026) — the inflection print:
Q3 FY26 quarterly (to 31-Mar-2026):
vs consensus: no clean consensus beat/miss figure is sourceable — n/a. The market reaction tells the story instead.
Guidance & the tone shift — the critical negative. On 24-April-2026 IGO cut FY26 Greenbushes guidance: spodumene production to 1.375–1.425Mt (from 1.5–1.65Mt, ~−11% at midpoint) and unit cash cost to A$380–420/t (from A$310–360/t, ~+19–25%). MD Ivan Vella called the quarter "disappointing" and said performance had been challenged across safety, feed grade, recoveries, maintenance execution and plant reliability, with "many of these issues are systemic". This is the single most important sentence in the file: the crown jewel is showing structural, not transitory, operating stress — and the mechanism (lower feed grade → more ore through the plant for the same concentrate → strain on reliability) is geological, not a one-off.
Balance-sheet flags: clean. Net cash A$327M, negligible debt, Kwinana impairment already taken (the bad news is on the page, not hiding). Inventory/receivables detail not separately sourceable (n/a). The risk is operational/asset, not financial leverage.
Market reaction: two regimes. (1) The April-2026 "systemic problems" guidance cut triggered an ~18% single-day fall to A$7.01 — the worst in over a decade. (2) Yet over the trailing year the stock is up ~124% on the lithium-price recovery, last around A$9.25 versus a 52-wk high of A$10.05. The tape says: the macro (lithium price) dominates the micro (Greenbushes operating cracks) — for now.
transcripts/ empty — ``-sourced from call/results summaries.
Arc of management messaging, FY24 → Q3 FY26:
Recurring phrases: "world-class asset," "lowest-cost hard-rock lithium," "through the cycle," "disciplined capital allocation," "portfolio rationalisation." What they stopped saying: the bullish multi-asset nickel-growth language of the 2021–22 Western Areas era. "Nickel" has gone from thesis → liability → exit.
Net sentiment read: improving on the macro, but with a fresh and serious crack of candour about the crown jewel's operating health. Management credibility is recovering but not restored — they are still cleaning up the prior team's mess while now having to explain new problems at the one asset that was supposed to be bulletproof.
| Company | Ticker | Mkt cap | EV/EBITDA (fwd, JPM) | P/E | Div yield | 5yr avg ROE | Source |
|---|---|---|---|---|---|---|---|
| IGO Ltd | IGO.AX | ~A$7.0B (≈A$9.25 × 757M) | 2.7x | n/a (transitioning) | 0.0% (suspended) | n/a | |
| Pilbara Minerals | PLS.AX | ~US$11.4B (Mar-2026) | 6.7x | n/a | n/a | n/a | |
| Mineral Resources | MIN.AX | n/a | 5.5x | n/a | n/a | ||
| Liontown Resources | LTR.AX | n/a | 2.0x | n/a | n/a | ||
| Albemarle | ALB (NYSE) | n/a | n/a | n/a | n/a | not sourced this run | |
| SQM | SQM (NYSE) | n/a | n/a | n/a | n/a | not sourced this run |
Sector context + the analyst split. Large-cap ASX lithium is trading ~6.7x (PLS) down to ~2.0x (LTR) on forward EV/EBITDA, with the spread "almost entirely a function of the assumed long-run spodumene price". Macquarie's stance is instructive: Neutral on PLS, Underperform on MIN and LTR, while framing IGO as the name whose FY27 earnings roughly triple on the price recovery.
The read — and the trap. IGO screens "cheapest" at 2.7x. But that headline is misleading: IGO's reported EBITDA is contaminated by consolidated nickel (being wound to zero) and excludes the equity-accounted Greenbushes profit it actually owns. A clean comparison values IGO as net cash (~A$327M) + 24.99% of Greenbushes' value + 49% of a ~zero-value Kwinana − closure/rehab liabilities − corporate overhead. On a look-through basis IGO is not obviously the cheapest in the group — it is a stub on one asset. Macquarie's framing is the honest one: the appeal is lithium-price torque (FY27 earnings tripling), not IGO being structurally undervalued versus PLS.
Mostly ``.
What the pattern reveals: IGO trades as a high-beta proxy on the spodumene price, full stop. Idiosyncratic news (M&A, impairments, even a fire at the crown jewel) moves it, but the dominant variable by an order of magnitude is the lithium price. Buy/sell IGO and you are really making a lithium-price call with operating and governance leverage bolted on. The April-2026 fall is the one telling exception: when the crown jewel itself is the bad news (not the macro), the market punishes it hard — then forgot about it weeks later when the fire spiked prices.
CEO/MD — Ivan Vella (appointed Dec-2023, ~2.5yr tenure).
our figures absent). The finance function is a live red flag: Kathleen Bozanic → Ian Rowe (interim) → Johan van Vuuren appointed effective 1-Apr-2026 — who then resigned effective 29-Apr-2026, after under a month ("the role was not the right fit for his career aspirations"). That is four CFO events in ~two years, one lasting 29 days. Even if benign, a CFO walking inside a month, weeks after the worst single-day share fall in a decade, is the kind of finance-function instability that demands scrutiny.Net: a competent, credible cleanup operator running a company whose prior leadership destroyed substantial capital — but now carrying a visibly unstable finance function. The bet on management is a bet that Vella can (a) extract IGO cleanly from Kwinana (on Tianqi's terms), (b) close nickel without ugly rehab surprises, (c) actually manage the newly-disclosed structural problems at Greenbushes (largely outside his control as a 24.99% minority), and (d) stabilise the CFO seat.
our figures empty — figures ``; this lens is necessarily lighter than a filing-grounded one. Flagged honestly as such.
Accounting / disclosure risk areas:
Regulatory findings (required sub-section).
total_sec_findings: 0.n/a for specific litigation.Web-only, no our figures, no our figures EPS line — so this is a directional `` built from sourced inputs, not a precise bottom-up model. EPS sensitivity to the spodumene price is enormous; I express the projection as scenarios on realised SC6 price, the one variable that matters. No our model create is run (watchlist/unattended rule + the projection is too price-dependent to commit a Brier point honestly).
Anchor facts: ~757M shares; net cash A$327M at 31-Mar-2026; FY26 Greenbushes production guidance 1.375–1.425Mt @ A$380–420/t cash cost; IGO's economic share = 24.99%; Nova contributes through ~late-2026 then →0 (rehab cash out from 2027); Kwinana ≈ breakeven-to-loss, treated as ~zero value; dividend suspended.
Macro backdrop is now two-sided and tilting bullish on spodumene specifically. Fastmarkets raised its 2026 lithium forecast to US$23.80/kg (from US$17.40) and 2027 to US$31.40/kg (from US$22.65), and sees a structural spodumene deficit in 2026 (converter overcapacity, Australian curtailments, Jiangxi/Jianxiawo lepidolite suspensions). But the dispersion is real: BMI expects the broad lithium market to stay in surplus to 2029 before a 2030s deficit. So the bull and bear scenarios below are both live.
| Scenario | Realised SC6 (US$/t) | FY26–28 trajectory | Notes |
|---|---|---|---|
| Bear | ~US$1,000–1,200 (recovery fades; BMI surplus view) | Greenbushes EBITDA contribution falls; IGO underlying EPS stays thin/near-breakeven; nickel rolls off late-2026 leaving Greenbushes the only engine | Macquarie's "triple FY27 earnings" evaporates; stock de-rates toward look-through net-cash + a depressed, grade-impaired Greenbushes |
| Base | ~US$1,500 (consensus recovery holds) | IGO returns to clear profitability in FY26; FY27 earnings ~triple as full-year recovered prices flow through 24.99% of Greenbushes; dividend likely resumes FY27 | The consensus path. Stock ~fairly valued look-through after the +124% run |
| Bull | ~US$2,000+ (Fastmarkets-style deficit; ESS demand) | Greenbushes ~75%-margin economics × 24.99% throw off large distributions; net cash compounds; meaningful capital returns; CGP3 (once de-risked post-fire) adds ~500ktpa capacity | The lithium-bull case; IGO is high-torque, balance-sheet-safe exposure to it |
Specific EPS figures: n/a (no clean consensus EPS line obtained; declining to fabricate one). The honest projection statement: IGO's three-year earnings are a leveraged function of the spodumene price × 24.99% of Greenbushes' (now grade-impaired, higher-cost) volumes, plus a net-cash cushion, minus a winding-down nickel business and a ~zero refinery. Base case (US$1,500 SC6) = clear return to profit in FY26 and a ~3x FY27 earnings jump — that is consensus, not contrarian.
Bull case. You are buying 24.99% of the single best hard-rock lithium asset on the planet at a moment when the lithium price has decisively turned (carbonate ~doubled to ~US$26.3k/t; SC6 to US$1,668/t ) and the company is already debt-free with A$327M net cash. Greenbushes earns above WACC even at the trough (66% margin, ~A$1.5B cash flow at the bottom ). The nickel albatross is nearly gone; Kwinana is fully impaired (downside recognised). If spodumene runs to deficit on ESS + EV demand, IGO is high-torque, balance-sheet-safe exposure with FY27 earnings tripling and a probable dividend resumption. The market re-rated it ~124% and it can still work if the cycle has legs.
Bear case (the permanent-impairment risks).
Pre-mortem (18 months out, thesis broke — what happened?): Lithium rolled over again (Chinese lepidolite restarts + African supply + slowing EV growth overwhelmed ESS demand, vindicating BMI's surplus call); SC6 fell back toward US$1,000. Simultaneously Greenbushes' "systemic" problems proved persistent — grade decline + post-fire CGP3 delays kept volumes low and unit costs high — so IGO got the worst of both: a falling price on shrinking, costlier volumes. Nickel closure threw up rehab cost surprises and the CFO seat stayed unstable. The 124% re-rate unwound and IGO round-tripped toward A$4–6.
Are multiples too high? Headline 2.7x EV/EBITDA looks cheap but is contaminated (Lens 7). On a clean look-through, after the 124% run, IGO is fairly-to-fully valued for the base case — not cheap optionality anymore; a consensus lithium-recovery long with asset-specific cracks, trading slightly above the analyst consensus PT.
Contrarian view (what the market is refusing to see): The market is treating IGO as a clean leveraged lithium proxy and rewarding it accordingly — while quietly ignoring that the crown jewel itself just told you its problems are structural, not cyclical. The bull narrative ("world-class lowest-cost asset, buy the cycle") is fighting a slow, permanent erosion of the very cost advantage that defines the asset — visible in the 1.9%→1.6% grade convergence. The April-2026 18% one-day fall was the market briefly seeing it, then forgetting as the fire spiked prices. Greenbushes getting permanently more expensive to run is the under-priced risk.
Dismantling the bull case as a skeptical short.
| Industry | Critical Materials |
| Size | Public Company |
Where IGO Ltd sits against the other names we cover on this beat. Each line is that company’s verdict, not a summary of it.
The bear case fired — but through a door the prior dossier wasn't watching, and the stock overshot it.
Cash $1.4B
The bear case got tested on its own terms and lost
Cash $7.3B
The June thesis inverted on the arithmetic, not the story
Cash $568M
A fully-funded, government-backed option on the first US commercial-scale lithium mine
A single-asset, equity-accounted 44.8% call option on Cauchari-Olaroz